A class of optimal covariate-adjusted response adaptive procedures is developed for phase III clinical trials when the treatment response is a survival time and there is random censoring. The basic aim is to develop an allocation design by combining the ethical aspects with statistical precision in a reasonable way under the presence of covariate information. Considering minimisation of total hazards as the ethical requirement, the proposed procedure is assessed in terms of the assignment to the better treatment and the efficiency (i.e. power) to detect a small departure in treatment effectiveness. The applicability of the proposed methodology is also illustrated using a real data set.
PongAChowSC. Overview of adaptive design methods in clinical trials. In: Handbook of adaptive designs in pharmaceutical and clinical development, Boca Raton, New York: CRC Press, 2011.
BiswasABhattacharyaR. Response-adaptive designs for continuous treatment responses in phase III clinical trials: A review. Stat Meth Med Res. 49: 928–940..
4.
SpostoRKrailoMD. Use of unequal allocation in survival trials. Stat Med1987; 7: 629–637.
5.
HsiehFY. Comparing sample size formulas for trials with unbalanced allocation using the logrank test. Stat Med1992; 11: 1091–1098.
6.
FlehingerBLouisT. A sequential treatment allocation in clinical trials. Biometrika1971; 58: 419–426.
7.
YaoQWeiLJ. Play the winner for phase II and III clinical trials. Stat Med1996; 15: 2413–2423.
8.
HallstromABrooksMMPeckoviaM. Logrank, play the winner, power and ethics. Stat Med1996; 15: 2135–2142.
RosenbergerWFAdaptive survival trials. In: Shein-Chung (ed). Encyclopedia of biopharmaceutical statistics2003, 2nd ed. Marcel Dekker Inc., New York, 16–17.
11.
ZhangLRosenbergerWF. Response-adaptive randomization for survival trials: The parametric approach. J R Stat Soc Ser C2007; 34: 562–569.
12.
SverdlovOTymofyeyevYWongWK. Optimal response adaptive randomized designs for multi-armed survival trials. Stat Med2011; 30: 2890–2910.
13.
BandyopadhyayUBiswasABhattacharyaR. A Bayesian adaptive design for two-stage clinical trials with survival data. Lifetime Data Anal2009; 15: 468–492.
14.
SverdlovORyeznikYWongWK. Doubly adaptive biased coin designs for balancing competing objectives in time-to-event trials. Stat Interface2012; 5: 401–413.
15.
HuFRosenbergerWF. The theory of response-adaptive randomization in clinical trials, New York: Wiley Interscience, 2006.
16.
ZhangLXHuFCheungSHet al.Asymptotic properties of covariate-adjusted response-adaptive designs. Ann Stat2007; 35: 1166–1182.
17.
BandyopadhyayUBiswasABhattacharyaR. A covariate adjusted two stage allocation design for binary responses in randomized clinical trials. Stat Med2007; 26: 4386–4399.
18.
ZhangL-XHuF. A new family of covariate-adjusted response adaptive designs and their properties. Appl Math J Chin Univ2009; 24: 1–13.
19.
BandyopadhyayUBiswasABhattacharyaR. A covariate-adjusted adaptive design for two-stage clinical trials with survival data. Stat Neerland2010; 64: 202–226.
20.
BandyopadhyayUBhattacharyaR. An urn based covariate adjusted response adaptive allocation design. Stat Meth Med Res2012; 21: 135–148.
21.
BandyopadhyayUBhattacharyaR. A covariate adjusted response adaptive allocation in clinical trials for a general class of responses. Stat Med2013; 32: 5053–5061.
22.
KoziolJAGreenSB. A Cramer-von Mises statistic for randomly censored data. Biometrika1976; 63: 465–474.
23.
LawlessJF. Statistical models and methods for lifetime data, 2nd ed. Hoboken, NJ: John Wiley & Sons, 2003.
24.
AndersonPKBorganØGillRDet al.Statistical models based on counting processes, New York: Springer, 1993.
25.
CsorgoSHorvathL. On the Koziol-Green model for random censorship. Biometrika1981; 68: 391–401.
26.
ChenCH. A correlation goodness-of-fit test for randomly censored data. Biometrika1984; 71: 315–322.
27.
ChengCHLinGD. Maximum likelihood estimation of a survival function under the Koziol-Green proportional hazards model. Stat Prob Lett1987; 5: 75–80.
28.
GijbelsIVeraverbekeN. Quantile estimation in the proportion hazards model of random censorship. Commun Stat Theory Meth1989; 18: 1645–1663.
29.
SubramanianS. Efficient estimation of regression coefficients and baseline hazard under proportionality of conditional hazard. J Stat Plann Inference2000; 84: 81–94.
30.
DauxoisJ-YKirmaniSNUA. On testing the proportionality of two cumulative incidence functions in a competing risks setup. Nonparametric Stat2003; 16: 479–491.
BiswasAMandalSOptimal adaptive designs in phase III clinical trials for continuous responses with covariates. In: Di BucchianicoALauterHWynnHP (eds). mODa 7 – advances in model-oriented design and analysis, Heidelberg: Physica-Verlag, 2004, pp. 51–58.
33.
WongWKZhuW. Optimum treatment allocation rules under a variance heterogeneity model. Stat Med2008; 27: 4581–4595.
34.
KalbfleischJDPrenticeRL. The statistical analysis of failure time data, Hoboken, NJ: Wiley Interscience, 2002.
